Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5218937
Max Phase: Preclinical
Molecular Formula: C25H29FN4O2
Molecular Weight: 436.53
Associated Items:
ID: ALA5218937
Max Phase: Preclinical
Molecular Formula: C25H29FN4O2
Molecular Weight: 436.53
Associated Items:
Canonical SMILES: NC(=O)c1ccc(C(=O)N2CCC(CNCCCc3c[nH]c4ccc(F)cc34)CC2)cc1
Standard InChI: InChI=1S/C25H29FN4O2/c26-21-7-8-23-22(14-21)20(16-29-23)2-1-11-28-15-17-9-12-30(13-10-17)25(32)19-5-3-18(4-6-19)24(27)31/h3-8,14,16-17,28-29H,1-2,9-13,15H2,(H2,27,31)
Standard InChI Key: WVRGMDHIIKCFCK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 436.53 | Molecular Weight (Monoisotopic): 436.2275 | AlogP: 3.48 | #Rotatable Bonds: 8 |
Polar Surface Area: 91.22 | Molecular Species: BASE | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.97 | CX Basic pKa: 10.31 | CX LogP: 2.93 | CX LogD: 0.18 |
Aromatic Rings: 3 | Heavy Atoms: 32 | QED Weighted: 0.47 | Np Likeness Score: -1.09 |
1. Yuan RX, Jiang KY, Wu JW, Zhang ZX, Li MS, Li JQ, Ni F.. (2022) Synthesis and antidepressant activity of novel 1-(1-benzoylpiperidin-4-yl) methanamine derivatives selectively targeting SSRI/5-HT1A., 76 [PMID:36202190] [10.1016/j.bmcl.2022.129006] |
Source(1):